Monthly update from the PB3 Personal Health Fund. “LP” (Limited Paul’s) is my network following along; “GP” (Genuine Paul) is the accountable, aspirational version of myself trying to show up. No real fund, investors, or capital exist — this is a personal brand device for tracking health, energy, and research the same way I’d track […]
An update on where I’ve been, what I’m focused on now, and where neurotech, mental health, and longevity are headed Hey, it’s been a while… To everyone who’s stuck with me since my last post back in December, thank you. I owe you an explanation and an update. The honest reason it’s taken this long […]
It’s Sunday Night Football! The camera cuts to slow motion as a linebacker launches himself at the quarterback. Bodies collide. The crowd roars. And inside the quarterback’s mouth, a $50 sensor the size of a stick of gum quietly logs the exact g-forces that just slammed his brain against his skull—acceleration, rotation angle, impact location, […]
Welcome to another edition of Neural Frontiers! This is a little different from how I’ve published posts before, but I’m really excited about it. Previously, I’ve worked on these by myself with minimal input from friends in the industry. I’ve been open to the idea of collaborating on a post with other industry friends, but […]
What Took Me So Long? Welcome back! You’re probably wondering why it took me a couple of months to publish the latest blog post. In April, I decided to join a scout program with a fund, with the intention of expanding my founder network and becoming more involved in generalist deal flow. What I learned […]
Introduction Black Mirror’s “Common People” episode presents a terrifying vision of neurotechnology gone awry—a brain implant that starts as a miracle cure but ultimately becomes a subscription-based nightmare. While fictional, this dystopian scenario raises crucial questions about the real-world trajectory of neurotechnology in 2025. Is this our inevitable future, or can we build something better? […]
Introduction The global neuromodulation market is projected to reach $13.3 billion by 2028, with pain management applications leading the charge. While these numbers alone should capture investor’s attention, they represent something far more significant: a massive unmet need at the intersection of neurodegenerative diseases and chronic pain. For venture capitalists and startups looking for that […]
Thank you all for the kind thoughts and gestures as I took a break from the blog last week due to my wife needing some extended time in the hospital. There is no better reminder as to how often we take our health for granted, than when you have to spend time in a hospital. […]
Introduction to Neurodegenerative Diseases According to the World Health Organization’s latest report on neurological disorders, the global cost of dementia reached $1.3 trillion in 2023 and is projected to exceed $2.8 trillion by 2030. This staggering economic burden has created an unprecedented market opportunity for early detection technologies. Venture funding in the broader neurotech sector […]
Welcome to March! Just like that we are onto our 9th post in Neural Frontiers. This week, I’m writing the blog post from my in-laws’ new home in North Carolina. Thankfully (very very thankfully) I have two In-laws approaching their 70s who are still mentally strong. However, this week’s post is still a difficult one […]
